Results 251 to 260 of about 134,162 (275)

Health-related quality of life of older adults residing in social housing: a cross-sectional descriptive study using the EQ-5D-5L. [PDF]

J Patient Rep Outcomes
Agarwal G, Popal S, Marzanek F, Angeles R, Pirrie M, Koester C, Brar J, Plishka M, Mahal G, Vanama M.   +9 more
europepmc   +1 more source

Intensive care decision‐making, survival and dying well: a mixed methods study with people who have been intensive care patients

Anaesthesia, Volume 81, Issue 10, Page 1367-1377, October 2026.
Summary Introduction Admission to the ICU involves experiential burdens and a risk of a negative dying experience if patients do not survive their critical illness. Many patients who are critically unwell, or their surrogate decision‐makers, must decide about accepting ICU treatment without knowing what it is like.
Thomas Donaldson, Kirsty Keywood, Lucy Frith, Søren Holm   +3 more
wiley   +1 more source

Locked-Window EQ-5D-5L (Index and VAS) Benchmarking in Sarcoma Care: Rule-Based Traffic-Light Classification Across Two Institutions. [PDF]

Diseases
Gloor I, Meier B, Rexhai J, Heesen P, Schelling G, Vogel B, Studer G, Fuchs B, On Behalf Of The Swiss Sarcoma Network.   +8 more
europepmc   +1 more source

Cost‐effectiveness analysis of total intravenous vs. inhalation anaesthesia among adults aged ≥ 50 y undergoing major non‐cardiac surgery

Anaesthesia, Volume 81, Issue 10, Page 1378-1385, October 2026.
Summary Introduction Total intravenous and inhalational anaesthesia are used widely to maintain general anaesthesia for major non‐cardiac surgery, yet their comparative cost‐effectiveness remains uncertain. The VITAL trial evaluated clinical outcomes, showing no difference in days alive and at home at 30 days.
Samuel Frempong, Rebecca Kandiyali, James Mason, Louise Hiller, Janet Dunn, Katie Booth, Ramani Moonesinghe, Rupert Pearse, Ben Shelley, Shaman Jhanji, Joyce Yeung, on behalf of the VITAL Trial Team   +11 more
wiley   +1 more source

Correction: Validity of EQ-5D-5L breathing and cognition bolt-ons in non-hospitalized patients after COVID-19. [PDF]

Qual Life Res
Stavem K, Garratt AM.
europepmc   +1 more source

Impact of Osilodrostat on Health‐Related Quality of Life in Cushing's Disease: Analysis of Patient‐Reported Outcomes From the Phase III LINC 3 and LINC 4 Clinical Trials

Clinical Endocrinology, Volume 105, Issue 4, Page 452-463, October 2026.
ABSTRACT Objective Evaluate the effects of osilodrostat short‐ and long‐term treatment on health‐related quality of life (HRQoL) in Cushing's disease. Design LINC 3 and LINC 4 studies (pooled analysis). Patients 185 patients (mean baseline total scores: Cushing's Quality of Life [CushingQoL], 44.0; Beck Depression Inventory II [BDI‐II], 15.6; EuroQol ...
John Newell‐Price, Beverly M. K. Biller, Maria Fleseriu, Beatrice Gueron, Grzegorz Binowski, Anna Paćkowska, Mônica R. Gadelha   +6 more
wiley   +1 more source

Validity of EQ-5D-5L breathing and cognition bolt-ons in non-hospitalized patients after COVID-19. [PDF]

Qual Life Res
Stavem K, Garratt AM.
europepmc   +1 more source

Fruquintinib: Mechanism of Action, Clinical, and Translational Science

Clinical and Translational Science, Volume 19, Issue 10, October 2026.
ABSTRACT Fruquintinib is a highly selective, oral inhibitor of all three vascular endothelial growth factor receptors (‐1, ‐2, and ‐3) that was approved, including in China, the United States, and the European Union, for the treatment of previously treated metastatic colorectal cancer (mCRC).
Xiaofei Zhou, Arvind Dasari, Jin Li, Caly Chien, Qi Dong, Lucy Chen, Lixian Dong, Neeraj Gupta   +7 more
wiley   +1 more source

Validity and responsiveness of the EQ-5D-5L, EQ-HWB and EQ-HWB-9 to measure health and wellbeing impact of heatwaves among older adults. [PDF]

Health Qual Life Outcomes
Liao M, Rencz F, Yang Z, Xiang J, Luo N.
europepmc   +1 more source

A comparative study of EQ-5D-5L and SF-6D scales based on patients receiving oral anticoagulant therapy. [PDF]

Health Qual Life Outcomes
Dong S, Li Y, Liao Z, Lin Q, Yiu HHE, Ming WK, Li L, Zhao R.   +7 more
europepmc   +1 more source